Location: Home
  • search
  • go
  • Relate News
  • 4/3/2026Yifan/Evive Expands Ryzneuta Europe Footprint With France Licensing De...
  • 4/3/2026XellSmart Secures CNY 500M+ to Accelerate Parkinson's, ALS and SCI iPS...
  • 4/3/2026Myeloid Cure Biotech Secures Over CNY 150M in Series A to Advance Mac...
  • 4/3/2026Recent Executive Moves
  • 4/3/2026NMPA Suspends Import, Sale and Use of Cadila's Amlodipine Besylate API...
  • 4/3/2026China's $13B Pharma Boom Drives Growth But Faces Hurdles in US and EU ...
  • 4/2/2026NMPA Issues Notice on Advancing Segmented Manufacturing of Biologics
  • 4/2/2026NMPA Releases Implementation Opinions on "AI + Drug Regulation"
  • 4/1/2026Pierre Fabre Deepens China Commitment as Pharma and Dermo-Cosmetics Gr...
  • 4/1/2026China Tightens Health Insurance Fund Oversight With New Anti-Fraud Rul...
  • 4/1/2026Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...
  • 3/31/2026Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...
  • 3/31/2026Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...
  • 3/31/2026Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...
  • 3/31/2026Connect Biopharma Reports Promising Late-Stage China Results for Eczem...
  • 3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...
  • 3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework
  • 3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...
  • 3/31/2026IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing
  • 3/30/2026GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma
  • 3/30/2026AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP
  • 3/30/2026Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...
  • 3/30/2026China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...
  • 3/30/2026BioRay and UCB Win Dual China Dermatology Approvals for Bimzelx
  • 3/30/2026Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...
  • 3/27/2026China Pharma Market Set for Structural Shift as Innovation and Cost Pr...
  • 3/27/2026GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...
  • 3/27/2026SK Biopharma Launches Epilepsy Drug Cenobamate in China
  • 3/27/2026Recent Executive Moves
  • 3/25/2026Hope Medicine Advances HMI-115 Into Phase III for Endometriosis
  • Page:1/384 Total number of articles:11491: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group